Literature DB >> 11315852

Administration of troglitazone, but not pioglitazone, reduces insulin resistance caused by short-term dexamethasone (DXM) treatment by accelerating the metabolism of DXM.

H Morita, Y Oki, T Ito, H Ohishi, S Suzuki, H Nakamura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11315852     DOI： 10.2337/diacare.24.4.788

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  4 in total

1.  Improvement of glycemic control after a 3-5 day insulin infusion in type 2-diabetic patients with insulin resistance can be maintained with glitazone therapy.

Authors:  Georg Biesenbach; Peter Grafinger; Andreas Raml
Journal:  Wien Klin Wochenschr       Date:  2006-09       Impact factor: 1.704

2.  Glucagon-like peptide-1 receptor agonist treatment prevents glucocorticoid-induced glucose intolerance and islet-cell dysfunction in humans.

Authors:  Daniël H van Raalte; Renate E van Genugten; Margot M L Linssen; D Margriet Ouwens; Michaela Diamant
Journal:  Diabetes Care       Date:  2011-01-07       Impact factor: 19.112

3.  Effects of 6-month sitagliptin treatment on metabolic parameters in diabetic patients taking oral glucocorticoids: a retrospective cohort study.

Authors:  Hisayuki Katsuyama; Akahito Sako; Hiroki Adachi; Hidetaka Hamasaki; Hidekatsu Yanai
Journal:  J Clin Med Res       Date:  2015-04-08

4.  Dapagliflozin for prednisone-induced hyperglycaemia in acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Maaike C Gerards; Gerdien E Venema; Kornelis W Patberg; Martijn Kross; Bert Jan Potter van Loon; Ilse M G Hageman; Dominic Snijders; Dees P M Brandjes; Joost B L Hoekstra; Titia M Vriesendorp; Victor E A Gerdes
Journal:  Diabetes Obes Metab       Date:  2018-02-06       Impact factor: 6.577
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.